Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro (Q40571040)
Jump to navigation
Jump to search
scientific article published on April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro |
scientific article published on April 2004 |
Statements
1 reference
Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro (English)
1 reference
Peter J Houghton
1 reference
Glen S Germain
1 reference
Franklin C Harwood
1 reference
John D Schuetz
1 reference
Clinton F Stewart
1 reference
Elisabeth Buchdunger
1 reference
Peter Traxler
1 reference
1 April 2004
1 reference
1 reference
Identifiers
1 reference